Pulmonology lasers market seen reaching $8.36 billion by 2030

The pulmonology lasers market is projected to grow from $5.52 billion in 2025 to $8.36 billion by 2030, driven by rising respiratory disease cases, wider use of minimally invasive procedures and aging populations. North America held the largest regional share in 2025, according to The Business Research Company.

Why it matters: - The pulmonology lasers market is tied to demand for less invasive respiratory treatments that can reduce recovery time and procedural trauma. - Growth in lung cancer, airway tumors and chronic respiratory disease is expanding the need for laser-based diagnosis and treatment. - The market’s projected rise to $8.36 billion by 2030 signals continued investment in specialized pulmonology equipment and care settings.

What happened: - The Business Research Company released a pulmonology lasers market report covering market size, trends and a global forecast for 2026-2035. - The report pegs the market at $5.52 billion in 2025 and $6.04 billion in 2026, implying 9.5% growth. - The market is forecast to reach $8.36 billion by 2030, at a 8.5% CAGR over the outlook period. - North America held the largest share of the pulmonology lasers market in 2025. - The report also covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - A free sample is available here. - The full report is available here.

The details: - Pulmonology lasers are designed to diagnose and treat respiratory conditions by emitting high-energy light beams that target abnormal or diseased lung tissue. - The technology aims to offer less invasive alternatives to traditional surgery. - The report links market growth to a rise in lung cancer and airway tumor cases, wider use of interventional pulmonology, more laser-enabled medical centers, broader clinical acceptance and ongoing laser innovation. - It also cites stronger demand for minimally invasive respiratory treatments, more funding for advanced pulmonology equipment, broader adoption of laser-based tumor management and improved laser precision and control. - Reported trends include greater use of minimally invasive laser therapies, increased ND-YAG laser use in airway procedures, demand for accurate tissue ablation, expansion of photodynamic laser uses and more focus on procedural safety and effectiveness. - The report says chronic respiratory disease is a major growth driver because these conditions affect the airways and lung structure and can reduce quality of life. - A December 2023 JAMA Network Open study projected global COPD cases could approach 600 million by 2050, a 23% rise in prevalence. - The report says expanding use of minimally invasive surgery is also supporting demand for advanced laser technologies in bronchoscopic and thoracoscopic procedures. - Data from the American Society of Plastic Surgeons showed a 7% increase in minimally invasive procedures during 2023, outpacing surgical operations by 2%. - The report says an aging population is adding to demand because older adults often need specialized respiratory care. - The UK House of Commons Library reported 12.7 million people aged 65 or older in the UK in 2022, equal to 19% of the population, and projected that figure to reach 22.1 million, or 27%, by 2072.

Between the lines: - The market outlook reflects a broader healthcare shift toward precision tools that can treat airway problems with less patient disruption. - The strongest demand appears to be coming from two overlapping trends: more patients with respiratory disease and more procedures designed to avoid open surgery. - North America’s lead suggests the region has the installed clinical infrastructure and adoption base to convert new technology faster than other markets.

What's next: - The market is expected to keep expanding as respiratory disease rates rise and minimally invasive techniques become more common. - Growth should also track continued investment in advanced pulmonology systems and specialized respiratory care facilities. - The report’s forecast points to further adoption of laser-based tumor management and procedure-specific laser platforms through 2030.